KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Current Deferred Tax Assets: 2009

Historic Current Deferred Tax Assets for Alnylam Pharmaceuticals (ALNY) over the last 1 years, with Dec 2009 value amounting to $1.9 million.

  • Alnylam Pharmaceuticals' Current Deferred Tax Assets was N/A to $1.9 million in Q3 2010 from the same period last year, while for Sep 2010 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $1.9 million for FY2009, which is N/A change from last year.
  • Latest data reveals that Alnylam Pharmaceuticals reported Current Deferred Tax Assets of $1.9 million as of FY2009.
  • In the past 5 years, Alnylam Pharmaceuticals' Current Deferred Tax Assets ranged from a high of $1.9 million in FY2009 and a low of $1.9 million during FY2009.
  • For the 1-year period, Alnylam Pharmaceuticals' Current Deferred Tax Assets averaged around $1.9 million, with its median value being $1.9 million (2009).